Clinical Trial Update: Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on primary prophylaxis of cerebral toxoplasmosis in HIV-infected patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Toxoplasmosis Cerebral

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Toxoplasmosis, Cerebral, HIV Infections | Phase 2 | Status: COMPLETED